Results 181 to 190 of about 93,466 (259)

Reduced Vascular Complications After Catheter Ablation Applying Sonography‐Guidance and Modified Postprocedural Care

open access: yesJournal of Arrhythmia, Volume 42, Issue 2, April 2026.
Graphical abstract displaying periprocedural groin site management approaches in group I (left upper image) and group II (right upper image, figure‐of‐eight suture on the right hand side). In the center you can find the main results displayed as box plot (y‐axis: major [red] and minor [blue] vascular complications in %).
Niklas Schenker   +15 more
wiley   +1 more source

Incidence of ventricular arrhythmias in patients with chronic total coronary occlusion: Results of the VACTOR study. [PDF]

open access: yesInt J Cardiol Heart Vasc
Assaf A   +10 more
europepmc   +1 more source

Neuroprotective Effect of Remote Ischemic Conditioning on Patients Undergoing Intravenous Thrombolysis: A Randomized Controlled Trial

open access: yesMedComm, Volume 7, Issue 4, April 2026.
Adjunctive remote ischemic conditioning (RIC) administered twice within 24 h after intravenous thrombolysis (IVT) improved cerebral autoregulation, suggesting that RIC exerted neuroprotective effects in patients undergoing IVT. ABSTRACT Intravenous thrombolysis (IVT) is the treatment with the highest level of evidence for acute ischemic stroke, but ...
Shuang Qi   +11 more
wiley   +1 more source

International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. [PDF]

open access: yesEur Heart J Digit Health
Herman R   +23 more
europepmc   +1 more source

The anti‐fibrotic effects of novel heart failure pharmacotherapies in advanced heart failure patients

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 7, Page 1502-1516, April 2026.
Background and Purpose Novel heart failure (HF) pharmacotherapies, including angiotensin receptor‐neprilysin inhibitor (ARNI) and sodium‐glucose cotransporter 2 inhibitors (SGLT2is), may confer cardiovascular benefits by attenuating myocardial fibrosis. However, direct evidence from human failing myocardial samples is limited.
Dávid Nagy   +10 more
wiley   +1 more source

Epigenetic mechanisms and therapeutic innovations in chronic pain‐associated neuropsychiatric co‐morbidities

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 7, Page 1313-1340, April 2026.
Abstract Chronic pain, marked by nociceptive sensitization and maladaptive neuroplasticity, affects 30% of the global population with escalating socioeconomic burdens. Epidemiological data show a 2‐3‐fold increase in neuropsychiatric co‐morbidities among individuals with chronic pain, where epigenetic dysregulation serves as a key mechanism linking ...
Kai Zhang   +18 more
wiley   +1 more source

Impact of a Chronic Total Coronary Occlusion on the Incidence of Appropriate Implantable Cardioverter-Defibrillator Shocks and Mortality: A Substudy of the Dutch Outcome in ICD Therapy (DO-IT)) Registry. [PDF]

open access: yesJ Am Heart Assoc
van Veelen A   +22 more
europepmc   +1 more source

Baseline Cerebral Small Vessel Disease Predicting Long‐Term Cognitive Decline in Transient Ischemic Attack Patients

open access: yesEuropean Journal of Neurology, Volume 33, Issue 4, April 2026.
This study showed that CSVD imaging markers are present in over half of TIA patients and are independently associated with cognitive decline up to 3 years, with the strongest effect on memory. Also, CMBs seem to be the strongest predictive imaging biomarker of cognitive decline in TIA patients.
Paula Roesen   +16 more
wiley   +1 more source

Plasma‐Polymerized Nanoparticles Presenting Fibrillin‐1 Drive Rapid Re‐Endothelialization of Vascular Grafts

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 9, 6 March 2026.
Commercial vascular grafts are made from ePTFE, a highly hydrophobic, foreign material that fails at a high rate in small‐diameter applications. Plasma polymer nanoparticles (PPN) are a versatile material functionalisation tool, used here to present fibrillin‐1 fragment PF8 on the graft surface.
Bob S. L. Lee   +9 more
wiley   +1 more source

Microneedle Technology in Psoriasis Management: Mechanistic Insights, Technological Innovation, Clinical Progress, and Challenges

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 10, 13 March 2026.
This review explores the evolving role of microneedle systems in psoriasis management, highlighting their potential for enhanced drug delivery, diagnosis, and disease monitoring. It also discusses unmet clinical needs for psoriasis management and technical challenges, while outlining strategic directions to advance microneedle integration into routine ...
Fatma Moawad   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy